Medical Research & News

Research

Industry Spotlight: Adaptive Biotechnologies
Susan Thornton, CEO, interviewed Adaptive Biotechnologies, creators of an innovative diagnostic tool that can be used in cutaneous lymphoma.
Research

Research in Cutaneous Lymphoma: A Broad View
Since the development of the “scientific method,” people have been engaged in research in efforts to answer questions, solve problems, and add to our overall knowledge. Nowhere is this more evident than in the medical field, and in the study of cutaneous lymphoma.
Research

FLASH Study: Clinical Trial Update
Dr. Ellen Kim shares information about the role of clinical trials and specifically the FLASH [Fluorescent Light Activated Synthetic Hypericin] Study.
Research

Protein Can Help Identify Which Rashes Are Early Mycosis Fungoides
Chronic rash in a sun-protected area that doesn’t respond to topical treatment likely needs to be evaluated for mycosis fungoides, the most common variant of cutaneous T-cell lymphoma. Now, a new VA study reports that a protein expression can help make the diagnosis.
Research

Skin-Directed Tactics Optimal for Early Cutaneous Lymphoma
For patients with early-stage cutaneous lymphoma, skin-directed treatments, such as topical steroids and phototherapy, can slow or halt progression, but patients are also being treated with systemic therapies, according to the first-of-its kind research on this rare malignancy.
Answers from the Experts

FUTURE DIRECTIONS IN T-CELL CUTANEOUS LYMPHOMA
Advances are being made in improving diagnostic tools. Dr. Christiane Quelfeld presents what has become available and what the future holds.
Research

WHAT ARE FOCUS AREAS IN CUTANEOUS LYMPHOMA RESEARCH?
New breakthroughs in research offer hope of better treatments and may offer insight into the causes of cutaneous lymphoma.
Research

Modernizing Immunotherapy for Cutaneous T-cell Lymphoma
For decades, immunotherapy has been a cornerstone of systemic therapy for cutaneous T cell lymphoma (CTCL). It is therefore not surprising that modern immune-therapies, which target anti-tumor immunity in more sophisticated ways, have the potential to greatly improve our treatments for CTCL. 
Research

Epigenetics & Biology of Cutaneous T-cell Lymphomas
These are exciting times in cutaneous T-cell lymphoma (CTCL) research. The hard work of laboratory and clinical investigators worldwide is starting to bear fruit, and a number of basic discoveries in the genetic and epigenetic foundations of CTCL are now being translated into novel therapies, with great impact for patients.
Research

Medical Meeting Highlights: 3rd World Congress, T-Cell Lymphoma Forum and USCLC Annual Workshop
In a world that has 7,000 known rare diseases, with only 5% having any treatment available, the future of discovery and new treatment development in cutaneous lymphoma is promising. There is much hope for a brighter future for everyone living with this condition.
Research

Industry Spotlight: Soligenix
Soligenix, Inc. recently to talk about their clinical trial for treating early stage cutaneous lymphoma. The treatment process uses a new topical photosensitizing agent (synthetic hypericin) and fluorescent light.
Research

Industry Spotlight: miRagen Therapeutics
miRagen Therapeutics is a biotech company based in Boulder, Colorado that focuses on a specific cell mechanism of action called microRNA. miRagen is currently conducting a Phase I clinical trial in cutaneous lymphoma.
Research

Industry Spotlight: Actelion Pharmaceuticals
Actelion Pharmaceuticals Medical Affairs Director Badri Rengarajan, MD and Associate Director Gaurav Sharma, Pharm.D, talk about two unique projects initiated over the last year: the PROv Study is a prospective, observational study that is currently open with plans to enroll 300 MF patients who will participate for a two-year timeframe. The team also developed of a quality of life measurement tool for early stage disease.
Research

Industry Spotlight: Elorac
Elorac, Inc. is currently engaged in a Phase III clinical trial for topical naloxone, which targets itch in cutaneous lymphoma. Listen to the discussion to learn more about this innovative approach to managing the intense itch associated with the disease.